Abstract
A 64-year-old male was treated for acute myeloid leukemia with idarubicin and cytarabin. He developed pulmonary mycosis (radiologically consistent with aspergillosis), which responded to intravenous amphotericin B.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antibiotics, Antineoplastic / adverse effects*
-
Antibiotics, Antineoplastic / therapeutic use
-
Antifungal Agents / therapeutic use
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Cytarabine / adverse effects*
-
Cytarabine / therapeutic use
-
Fever
-
Humans
-
Idarubicin / adverse effects*
-
Idarubicin / therapeutic use
-
Leukemia / drug therapy*
-
Lung / diagnostic imaging
-
Lung / microbiology
-
Lung / pathology
-
Lung Diseases, Fungal / chemically induced*
-
Lung Diseases, Fungal / diagnostic imaging
-
Lung Diseases, Fungal / drug therapy
-
Male
-
Middle Aged
-
Radiography
Substances
-
Antibiotics, Antineoplastic
-
Antifungal Agents
-
Antimetabolites, Antineoplastic
-
Cytarabine
-
Amphotericin B
-
Idarubicin